Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The potential role of appetite in predicting weight changes during treatment with olanzapine
Michael Case, Tamás Treuer, Jamie Karagianis, et al.
BMC Psychiatry (2010) Vol. 10, Iss. 1
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Effects of Antipsychotic Medications on Appetite, Weight, and Insulin Resistance
Chao Deng
Endocrinology and Metabolism Clinics of North America (2013) Vol. 42, Iss. 3, pp. 545-563
Closed Access | Times Cited: 148
Importance of Early Weight Changes to Predict Long-Term Weight Gain During Psychotropic Drug Treatment
Frederik Vandenberghe, Mehdi Gholam‐Rezaee, Núria Saigí-Morgui, et al.
The Journal of Clinical Psychiatry (2015) Vol. 76, Iss. 11, pp. e1417-e1423
Open Access | Times Cited: 86
Metformin and Berberine Prevent Olanzapine-Induced Weight Gain in Rats
Yueshan Hu, Alan J. Young, Erik A. Ehli, et al.
PLoS ONE (2014) Vol. 9, Iss. 3, pp. e93310-e93310
Open Access | Times Cited: 73
The effects of second-generation antipsychotics on food intake, resting energy expenditure and physical activity
Cristina Cuerda, C. Velasco, Jessica Merchán‐Naranjo, et al.
European Journal of Clinical Nutrition (2013) Vol. 68, Iss. 2, pp. 146-152
Open Access | Times Cited: 61
Disordered Eating among People with Schizophrenia Spectrum Disorders: A Systematic Review
Anoop Sankaranarayanan, Karthika Johnson, Sanop J. Mammen, et al.
Nutrients (2021) Vol. 13, Iss. 11, pp. 3820-3820
Open Access | Times Cited: 36
The impacts of antipsychotic medications on eating-related outcomes: A mixed methods systematic review
Rasha Alkholy, Karina Lovell, Penny Bee, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0308037-e0308037
Open Access
Validation of the shortest version of the eating attitude test (EAT-7) as a screening tool for disordered eating in patients with first-episode schizophrenia
Feten Fekih‐Romdhane, Youssef Boukadida, Majda Cheour, et al.
Journal of Eating Disorders (2025) Vol. 13, Iss. 1
Open Access
Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism
Karen L. Teff, Sangwon F. Kim
Physiology & Behavior (2011) Vol. 104, Iss. 4, pp. 590-598
Open Access | Times Cited: 59
Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
Jing Huang, Gangrui Hei, Ye Yang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 35
Atypical antipsychotics and effects on feeding: from mice to men
Louise Benarroch, Chantel Kowalchuk, Virginia Wilson, et al.
Psychopharmacology (2016) Vol. 233, Iss. 14, pp. 2629-2653
Closed Access | Times Cited: 35
Exploring Patterns of Disturbed Eating in Psychosis: A Scoping Review
Nicolette Stogios, Emily R. Smith, Roshanak Asgariroozbehani, et al.
Nutrients (2020) Vol. 12, Iss. 12, pp. 3883-3883
Open Access | Times Cited: 29
Who is at risk for weight gain after weight‐gain associated treatment with antipsychotics, antidepressants, and mood stabilizers: A machine learning approach
Julia Eder, Catherine Glocker, Barbara B. Barton, et al.
Acta Psychiatrica Scandinavica (2024) Vol. 151, Iss. 3, pp. 231-244
Open Access | Times Cited: 3
Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
Jing Huang, Gangrui Hei, Ye Yang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 21
Eating behavior and obesity in bipolar disorder
Emily E. Bernstein, Andrew A. Nierenberg, Thilo Deckersbach, et al.
Australian & New Zealand Journal of Psychiatry (2015) Vol. 49, Iss. 6, pp. 566-572
Closed Access | Times Cited: 21
Differences in omega‐3 and omega‐6 polyunsaturated fatty acid consumption in people at ultra‐high risk of psychosis, first‐episode schizophrenia, and in healthy controls
Tomasz Pawełczyk, Elżbieta Trafalska, Agnieszka Pawełczyk, et al.
Early Intervention in Psychiatry (2015) Vol. 11, Iss. 6, pp. 498-508
Closed Access | Times Cited: 18
Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients
Robert C. Smith, Saumya Rachakonda, Saurabh Dwivedi, et al.
Psychiatry Research (2012) Vol. 199, Iss. 3, pp. 159-163
Closed Access | Times Cited: 20
Trajectories of Agouti-Related Protein and Leptin Levels During Antipsychotic-Associated Weight Gain in Patients With Schizophrenia
Stefan Ehrlich, Karolina Leopold, Julia V. Merle, et al.
Journal of Clinical Psychopharmacology (2012) Vol. 32, Iss. 6, pp. 767-772
Open Access | Times Cited: 20
The protective effect of thymoquinone over olanzapine-induced side effects in liver, and metabolic side effects
Sedat Bilğiç, Deniz Taştemir Korkmaz, Sebile Azırak, et al.
Bratislavské lekárske listy/Bratislava medical journal (2018) Vol. 118, Iss. 10, pp. 618-625
Open Access | Times Cited: 17
The association between polyunsaturated fatty acid consumption and the transition to psychosis in ultra-high risk individuals
Tomasz Pawełczyk, Elżbieta Trafalska, Magdalena Kotlicka‐Antczak, et al.
Prostaglandins Leukotrienes and Essential Fatty Acids (2016) Vol. 108, pp. 30-37
Closed Access | Times Cited: 15
No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia
Jie Li, Xue Li, Emily Liu, et al.
Schizophrenia Research (2013) Vol. 146, Iss. 1-3, pp. 40-45
Open Access | Times Cited: 15
Food craving and consumption evolution in patients starting treatment with clozapine
Marina Garriga, Andrea Mallorquí, Lourdes Serrano, et al.
Psychopharmacology (2019) Vol. 236, Iss. 11, pp. 3317-3327
Closed Access | Times Cited: 11
Antipsychotic induced metabolic changes & treatment response: A prospective study
Eesha Sharma, Ganesan Venkatasubramanian, Shivarama Varambally, et al.
Asian Journal of Psychiatry (2014) Vol. 11, pp. 39-44
Closed Access | Times Cited: 8
Validation of the shortest version of the Eating Attitude Test (EAT-7) as a screening tool for disordered eating in patients with first-episode schizophrenia
Feten Fekih-Romdhane, Youssef Boukadida, Majda Cheour, et al.
Research Square (Research Square) (2024)
Open Access
Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?
William Montgomery, Tamás Treuer, Wenyu Ye, et al.
Neuropsychiatric Disease and Treatment (2014), pp. 1287-1287
Open Access | Times Cited: 1
PMH5 Does Participation in a Weight Control Program Also Improve Clinical and Functional Outcomes for Chinese Patients with Schizophrenia Treated with Olanzapine?
William Montgomery, Tamás Treuer, W.W. Ye, et al.
Value in Health (2012) Vol. 15, Iss. 7, pp. A669-A669
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top